您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2013, Vol. 51 ›› Issue (2): 65-69.

• 临床医学 • 上一篇    下一篇

骨髓增生异常综合征患者RASSF1A基因启动子区甲基化及基因表达的缺失

徐佳, 宋强   

  1. 山东大学齐鲁医院血液科,  济南 250012
  • 收稿日期:2012-07-04 出版日期:2013-02-10 发布日期:2013-02-10
  • 通讯作者: 宋强(1965- ),男,教授,硕士生导师,主要从事骨髓增生异常综合征发病机制和治疗的研究。E-mail:qiangs303@sina.com
  • 作者简介:徐佳(1986- ),女,硕士研究生,主要从事骨髓增生异常综合征发病机制的研究。E-mail:383925490@qq.com
  • 基金资助:

    山东省科技厅项目(Y2006C63)

Deletion of the RASSF1A gene and promoter methylation in the bone marrow of patients with myelodysplastic syndromes

 XU Jia, SONG Qiang   

  1. Department of Hematology, Qilu Hospital of Shandong University, Jinan 250012, China
  • Received:2012-07-04 Online:2013-02-10 Published:2013-02-10

摘要:

目的   检测骨髓增生异常综合征(MDS)患者骨髓RASSF1A基因的表达水平及其启动子区甲基化状态,探讨RASSF1A基因异常甲基化在MDS发生发展中的作用,为去甲基化药物治疗MDS提供新靶点。方法   选取30例MDS患者为实验组,非恶性血液病患者15例为对照组,按MDS国际IPSS评分标准对实验组进行分组。应用甲基化特异性聚合酶链反应(MS PCR)、逆转录PCR(RT PCR)法检测两组患者骨髓RASSF1A基因mRNA表达水平及启动子区甲基化状态,对比地西他滨治疗前后的MDS患者RASSF1A基因的甲基化情况。结果   实验组RASSF1A基因甲基化率(73.33%)明显高于对照组(P<0.05),且中高危MDS患者骨髓RASSF1A基因甲基化率(81.8%)明显高于低危MDS患者(18.2%)(P<0.05);实验组RASSF1A基因mRNA表达水平明显低于对照组(P<0.05);经地西他滨治疗后,MDS患者RASSF1A基因的甲基化程度较初诊时降低。结论   MDS患者骨髓RASSF1A基因的异常甲基化与该基因的表达失活紧密相关,可能是MDS发生发展的机制之一;地西他滨能够逆转RASSF1A基因的甲基化,为地西他滨治疗MDS提供新的理论依据。

关键词: 基因;RASSF1A;DNA甲基化;CpG岛; 骨髓增生异常综合征

Abstract:

Objective   To examine the expression level  of   RASSF1A gene and the methylation status of its promoter region in  bone marrow of patients with myelodysplastic syndromes (MDS), and to explore the correlation between RASSF1A gene methylation pathogenesis and development of MDS, in order to provide a new target for demethylation drugs. Methods   30 patients with MDS were chosen as the study group and 15 patients with non-malignant hematological diseases were chosen as the control group. Divide the study group according to the MDS IPSS risk score.Methylation specific PCR(MS PCR) was employed to detect the methylation status of the RASSF1A gene promoter region in the 30 patients with MDS. Expression levels of RASSF1A mRNA were also determined by reverse transcription PCR (RT PCR).Contrast the RASSF1A methylation status of the MDS patients before and after using Decitabine. Results   The RASSF1A methylation rate of the study group (73.33%) was much higher than that of the control group(P<0.05), and the RASSF1A methylation rate of the medium-high risk MDS patients(81.8%) is obviously higher than that of the low-risk MDS patients(18.2%)(P<0.05);Meanwhile,the RASSF1A mRNA expression level of the study group was significantly lower than that of the control group(P<0.05).The RASSF1A methylation level of the MDS patient after Decitabine treatment was lower than that of newly diagnosed patients. Conclusion   A significant correlation existed between RASSF1A hypermethylation and the loss of expression of RASSF1A mRNA in MDS. The hypermethylation of the RASSF1A gene promoter region may be one of the mechanisms related to the pathogenesis of MDS. Decitabine can reduce the methylation levels in the RASSF1A gene and it also provides a new theoretical basis for using Decitabine as the treatment of MDS.

Key words: Gene; RASSF1A; DNA methylation; CpG island; Myelodysplastic syndrome

中图分类号: 

  • R551.3
[1] 翟珊珊1,丁卜同2,李海霞3,陈昀1,常亚丽1,桑坦1,郭农建1. 伴13号染色体缺失的多发性骨髓瘤患者CD138+细胞差异表达miRNAs的筛选[J]. 山东大学学报(医学版), 2013, 51(5): 80-84.
[2] 孙元欣1, 秦雪梅1, 刘希民2, 王立志2, 刘传方1, 刘璐1. 异基因造血干细胞移植后aGVHD与调节性T细胞、IL-35的相关性[J]. 山东大学学报(医学版), 2013, 51(3): 89-94.
[3] 桑坦1,丁卜同2,常亚丽1,陈昀1,李志红2,汪运山2,韩淑毅2,童书青2,郭农建1. 成人急性淋巴细胞白血病ETV6基因重排分析及其临床意义[J]. 山东大学学报(医学版), 2012, 50(3): 79-82.
[4] 周丽云,宋强,李丽珍,赵川莉,王鲁群. 骨髓异常增生综合征患者FLT3基因的表达及意义[J]. 山东大学学报(医学版), 2010, 48(4): 91-.
[5] . 骨髓增生异常综合征患者骨髓p15基因的表达缺失与启动子甲基化[J]. 山东大学学报(医学版), 2009, 47(10): 106-109.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!